PTPN2 attenuates T-cell lymphopenia-induced proliferation

Nature Communications

Volumn 5, Issue , 2014, Pages

  Wiede, Florian ^a   La Gruta, Nicole L ^b   Tiganis, Tony ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 7; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; T LYMPHOCYTE RECEPTOR; PTPN2 PROTEIN, MOUSE;

ANTIGEN; CELL ORGANELLE; ENZYME ACTIVITY; HOMEOSTASIS; IMMUNITY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; AUTOINFLAMMATORY DISEASE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS LINKING; CYTOKINE RESPONSE; FEMALE; FLOW CYTOMETRY; INFANT; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPENIA; MALE; MOUSE; NONHUMAN; THYMOCYTE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; DEFICIENCY; DISEASE MODEL; HOMEOSTASIS; IN VITRO STUDY; KNOCKOUT MOUSE; LYMPHOPENIA; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIATION RESPONSE; THYMUS;

ANIMALS; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; HOMEOSTASIS; IN VITRO TECHNIQUES; INTERLEUKIN-7; LYMPHOPENIA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 2; RADIATION EFFECTS; THYMUS GLAND;

EID: 84892992901     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4073     Document Type: Article

References (60)

1. Surh, C. D. & Sprent, J. Homeostasis of naive and memory T cells. Immunity 29, 848-862 (2008).
2. Hogquist, K. A., Baldwin, T. A. & Jameson, S. C. Central tolerance: learning self- control in the thymus. Nat. Rev. Immunol. 5, 772-782 (2005). (Pubitemid 41400851)
3. Sprent, J. & Surh, C. D. Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells. Nat. Immunol. 12, 478-484 (2011).
4. Ernst, B., Lee, D. S., Chang, J. M., Sprent, J. & Surh, C. D. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 11, 173-181 (1999). (Pubitemid 29428810)
5. Kassiotis, G., Zamoyska, R. & Stockinger, B. Involvement of avidity for major histocompatibility complex in homeostasis of naive and memory T cells. J. Exp. Med. 197, 1007-1016 (2003). (Pubitemid 36523198)
6. Kieper, W. C., Burghardt, J. T. & Surh, C. D. A role for TCR affinity in regulating naive T cell homeostasis. J. Immunol. 172, 40-44 (2004). (Pubitemid 38020453)
7. Ge, Q., Bai, A., Jones, B., Eisen, H. N. & Chen, J. Competition for self-peptide- MHC complexes and cytokines between naive and memory CD8+ T cells expressing the same or different T cell receptors. Proc. Natl Acad. Sci. USA 101, 3041-3046 (2004). (Pubitemid 38327731)
8. Winstead, C. J., Fraser, J. M. & Khoruts, A. Regulatory CD4+CD25+Foxp3+ T cells selectively inhibit the spontaneous form of lymphopenia-induced proliferation of naive T cells. J. Immunol. 180, 7305-7317 (2008).
9. Winstead, C. J. et al. CD4+CD25+Foxp3+ regulatory T cells optimize diversity of the conventional T cell repertoire during reconstitution from lymphopenia. J. Immunol. 184, 4749-4760 (2010).
10. Kieper, W. C. et al. Recent immune status determines the source of antigens that drive homeostatic T cell expansion. J. Immunol. 174, 3158-3163 (2005). (Pubitemid 40354015)
11. Min, B., Yamane, H., Hu-Li, J. & Paul, W. E. Spontaneous and homeostatic proliferation of CD4 T cells are regulated by different mechanisms. J. Immunol. 174, 6039-6044 (2005). (Pubitemid 40663791)
12. Hagen, K. A. et al. A role for CD28 in lymphopenia-induced proliferation of CD4 T cells. J. Immunol. 173, 3909-3915 (2004). (Pubitemid 39280754)
13. Li, Q. J. et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129, 147-161 (2007).
14. Sebzda, E. et al. Mature T cell reactivity altered by peptide agonist that induces positive selection. J. Exp. Med. 183, 1093-1104 (1996). (Pubitemid 26114803)
15. Walker, L. S. & Abbas, A. K. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat. Rev. Immunol. 2, 11-19 (2002). (Pubitemid 37328771)
16. Pircher, H., Rohrer, U. H., Moskophidis, D., Zinkernagel, R. M. & Hengartner, H. Lower receptor avidity required for thymic clonal deletion than for effector T-cell function. Nature 351, 482-485 (1991). (Pubitemid 21896624)
17. Todd, J. A. et al. Robust associations of four new chromosome regions from genome- wide analyses of type 1 diabetes. Nat. Genet. 39, 857-864 (2007). (Pubitemid 47018195)
18. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
19. Smyth, D. J. et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N. Engl. J. Med. 359, 2767-2777 (2008).
20. Espino-Paisan, L. et al. A polymorphism in PTPN2 gene is associated with an earlier onset of type 1 diabetes. Immunogenetics 63, 255-258 (2011).
21. Festen, E. A. et al. A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn's disease and celiac disease. PLoS Genet. 7, e1001283 (2011).
22. Long, S. A. et al. An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4(+) T cells. Genes Immun. 12, 116-125 (2011).
23. Wiede, F. et al. T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice. J. Clin. Invest. 121, 4758-4774 (2011).
24. Zikherman, J. & Weiss, A. Unraveling the functional implications of GWAS: how T cell protein tyrosine phosphatase drives autoimmune disease. J. Clin. Invest. 121, 4618-4621 (2011).
25. Tiganis, T. & Bennett, A. M. Protein tyrosine phosphatase function: the substrate perspective. Biochem. J. 402, 1-15 (2007).
26. Wiede, F. et al. Strain-dependent differences in bone development, myeloid hyperplasia, morbidity and mortality in Ptpn2-deficient mice. Plos One 7, e36703 (2012).
27. Azzam, H. S. et al. Fine tuning of TCR signaling by CD5. J. Immunol. 166, 5464-5472 (2001). (Pubitemid 32374167)
28. Azzam, H. S. et al. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J. Exp. Med. 188, 2301-2311 (1998). (Pubitemid 29028502)
29. Hogquist, K. A. et al. T cell receptor antagonist peptides induce positive selection. Cell 76, 17-27 (1994). (Pubitemid 24035278)
30. Pircher, H., Burki, K., Lang, R., Hengartner, H. & Zinkernagel, R. M. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342, 559-561 (1989). (Pubitemid 20005822)
31. Haluszczak, C. et al. The antigen-specific CD8+ T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion. J. Exp. Med. 206, 435-448 (2009).
32. Sarkar, S. et al. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205, 625-640 (2008). (Pubitemid 351439309)
33. Smith-Garvin, J. E., Koretzky, G. A. & Jordan, M. S. T cell activation. Annu. Rev. Immunol. 27, 591-619 (2009).
34. Jameson, S. C. Maintaining the norm: T-cell homeostasis. Nat. Rev. Immunol. 2, 547-556 (2002). (Pubitemid 37328730)
35. Tough, D. F., Borrow, P. & Sprent, J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272, 1947-1950 (1996). (Pubitemid 26234507)
36. Kennedy, M. K. et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191, 771-780 (2000).
37. Aoki, N. & Matsuda, T. A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus. Mol. Endocrinol. 16, 58-69 (2002). (Pubitemid 34044498)
38. Simoncic, P. D., Lee-Loy, A., Barber, D. L., Tremblay, M. L. & McGlade, C. J. The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3. Curr. Biol. 12, 446-453 (2002). (Pubitemid 34248890)
39. Posevitz, V. et al. Regulation of T cell homeostasis by the transmembrane adaptor protein SIT. J. Immunol. 180, 1634-1642 (2008).
40. Nutsch, K. M. & Hsieh, C. S. T cell tolerance and immunity to commensal bacteria. Curr. Opin. Immunol. 24, 385-391 (2012).
41. Tajima, M. et al. IL-6-dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing CD8+ T cells. J. Exp. Med. 205, 1019-1027 (2008). (Pubitemid 351679678)
42. Khoruts, A. & Fraser, J. M. A causal link between lymphopenia and autoimmunity. Immunol. Lett. 98, 23-31 (2005). (Pubitemid 40409815)
43. Datta, S. & Sarvetnick, N. Lymphocyte proliferation in immune-mediated diseases. Trends Immunol. 30, 430-438 (2009).
44. King, C., Ilic, A., Koelsch, K. & Sarvetnick, N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117, 265-277 (2004). (Pubitemid 38496245)
45. Datta, S. & Sarvetnick, N. E. IL-21 limits peripheral lymphocyte numbers through T cell homeostatic mechanisms. PLoS One 3, e3118 (2008).
46. Le Campion, A. et al. Lymphopenia-induced spontaneous T-cell proliferation as a cofactor for autoimmune disease development. Blood 114, 1784-1793 (2009).
47. Gonzalez-Quintial, R. et al. Systemic autoimmunity and lymphoproliferation are associated with excess IL-7 and inhibited by IL-7Ralpha blockade. PLoS One 6, e27528 (2011).
48. Calzascia, T. et al. CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity. Proc. Natl Acad. Sci. USA 105, 2999-3004 (2008). (Pubitemid 351723657)
49. van Vliet, C. et al. Selective regulation of tumor necrosis factor-induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase. Nat. Immunol. 6, 253-260 (2005). (Pubitemid 41724762)
50. Shields, B. J., Hauser, C., Bukczynska, P. E., Court, N. W. & Tiganis, T. DNA replication stalling attenuates tyrosine kinase signaling to suppress S phase progression. Cancer Cell 14, 166-179 (2008).
51. Tan, J. T. et al. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl Acad. Sci. USA 98, 8732-8737 (2001). (Pubitemid 32678096)
52. Perez-Villar, J. J. et al. CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1. Mol. Cell Biol. 19, 2903-2912 (1999). (Pubitemid 29144535)
53. Hebeisen, M. et al. SHP-1 phosphatase activity counteracts increased T cell receptor affinity. J. Clin. Invest. 123, 1044-1056 (2013).
54. Henao-Mejia, J. et al. The MicroRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis. Immunity 38, 984-997 (2013).
55. Dudda, J. C. et al. MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer. Immunity 38, 742-753 (2013).
56. Gracias, D. T. et al. The microRNA miR-155 controls CD8 T cell responses by regulating interferon signaling. Nat. Immunol. 6, 593-602 (2013).
57. Zhang, N. & Bevan, M. J. TGF-beta signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation. Nat. Immunol. 13, 667-673 (2012).
58. Taylor, M. A., Sossey-Alaoui, K., Thompson, C. L., Danielpour, D. & Schiemann, W. P. TGF-beta upregulates miR-181a expression to promote breast cancer metastasis. J. Clin. Invest. 123, 150-163 (2013).
59. Kuhn, R., Schwenk, F., Aguet, M. & Rajewsky, K. Inducible gene targeting in mice. Science 269, 1427-1429 (1995).
60. Reikvam, D. H. et al. Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression. Plos One 6, e17996 (2011).